(ES, Na+): calculated for C19H20O3Na [M + Na]+: 319.1310, found:
319.1306).
28.2 (OCMe3). LRMS (ES): m/z (%) = 540.2 ([M + Na]+, 100),
484.2 (90), 485.2 (13), 440.2 (18). HRMS (ES, Na+): calculated for
C31H35NO6Na [M + Na]+: 540.2386, found: 540.2362.
The latter compound (4.50 g, 15.18 mmol) was dissolved
in DMF (15 mL) and cooled to 0 ◦C. NaH (purum, 0.47 g,
19.7 mmol) was then added. After 10 min, BnBr (2.0 mL,
16.7 mmol) was added dropwise and the reaction mixture was
warmed to room temperature. After 12 h, the solution was
hydrolyzed with water (70 mL) and the aqueous phase was
extracted with a cyclohexane–CH2Cl2 solution (90 : 10, 3 ×
60 mL). The combined organic phases were dried over magnesium
sulfate, filtered and concentrated. The residue was purified by flash
chromatography on silica gel (cyclohexane–ethyl acetate = 95 : 5)
to give 4.04 g (69%) of compound 23 as a pale yellow oil that
slowly crystallized to white crystals.
(3R,6S)-6-(4-Benzyloxy-3-methoxy-phenyl)-3-benzyloxy-methyl-
3,6-dihydro-2H-[1,2]oxazin-2-ium chloride (15)
To a solution of dihydrooxazine 24 (0.30 g, 0.58 mmol) in dioxane
(1 mL) at 0 ◦C was added HCl (4 N in dioxane, 0.58 mL,
2.32 mmol). White crystals precipitated after 1 h at 0 ◦C. After
filtration, the solids were washed with pentane and dried under
high vacuum to give 0.178 g (68%) of the desired 15 as white
crystals.
Mp: 143 ◦C (decomp.). 1H NMR (300 MHz, CD3OD), d (ppm):
7.47–7.30 (10 H, 2 × Ph); 7.01 (1 H, d, J 8.1, Ar.); 6.94–6.88 (2
◦
1
Mp: 43 C. H NMR (300 MHz, CDCl3), d (ppm): 7.50–7.30
(10 H, 2 × Ph); 7.01 (1 H, d, J 1.7, H Ar); 6.90 (1 H, dd, J 1.7
and 8.2, H Ar); 6.84 (1 H, d, J 8.2, H Ar); 6.70 (1 H, dd, J 10.5
=
H, Ar.); 6.23 (1 H, br. dt, J 1.3 and 10.8, OCH–CH CH–CHN);
=
6.13 (1 H, ddd, J 1.9, 4.3 and 10.8, OCH–CH CH–CHN); 5.81 (1
=
=
H, br. d, J 1.7, OCH–CH CH–CHN or OCH–CH CH–CHN);
5.15 (2 H, s, ArOCH2Ph); 4.67 (2 H, s, CH2OCH2Ph); 4.33 (1 H, m,
=
=
and 15.2, Ar–CH CH–CH CH–CH2); 6.52 (1 H, d, J 15.2, Ar–
=
=
=
=
CH CH–CH CH–CH2); 6.42 (1 H, m, Ar–CH CH–CH CH–
=
=
OCH–CH CH–CHN or OCH–CH CH–CHN); 3.83–3.79 (5 H
including 3.80 (3 H, s, OCH3), CH2OCH2Ph). 13C NMR (75 MHz,
CD3OD), d (ppm): 151.2 (Ar. Quat.), 150.9 (Ar. Quat.), 138.6 (Ar.
Quat.), 138.3 (Ar. Quat.), 130.4, 129.5, 129.2, 129.1, 129.0, 128.6,
122.8, 120.8 (Ar.), 115.1 (Ar.), 113.5 (Ar.), 81.6 (OCMe3), 74.4
(OCHPh), 71.8 (OCH2Ph), 67.5 (OCH2Ph), 56.6 (CH2OCH2Ph
or CH3O), 55.8 (CH2OCH2Ph or CH3O). LRMS (ES): m/z (%) =
440.1 ([M − Cl + Na]+, 100), 418.2 (28), 409.2 (22). HRMS (ES,
Na+): calculated for C26H28NO4Na [M − Cl + Na]+: 441.1916,
found: 441.1903.
=
=
CH2); 5.92 (1 H, dt, J 6.1 and 15.2, Ar–CH CH–CH CH–CH2);
5.19 (2 H, s, CH2OCH2Ph); 4.57 (2 H, s, ArOCH2Ph); 4.14 (2 H,
d, J 6.1, Ar–CH CH–CH CH–CH2); 3.94 (3 H, s, OCH3). 13C
NMR (75 MHz, CDCl3), d (ppm): 149.6 (Ar. Quat.), 148.0 (Ar.
Quat.), 138.2 (Ar. Quat.), 137.0, 133.2, 132.5 (Ar. Quat.), 130.7,
129.1, 128.5, 128.4, 127.8, 127.75, 127.6, 127.2, 126.6, 119.6 (Ar),
113.8 (Ar), 109.1 (Ar), 72.0 (CH2O), 70.9 (CH2O), 70.5 (CH2O),
55.9 (OCH3). LRMS (ES): m/z (%) = 459.2 (40), 443.2 (24), 425.2
(45), 358.2 (14), 357.1 (100).
=
=
(3R,6S)-6-(4-Benzyloxy-3-methoxy-phenyl)-3-benzyloxymethyl-
3,6-dihydro-[1,2]oxazine-2-carboxylic acid tert-butyl ester (24)
(2E,4E)-5-(3-Bromo-phenyl)-penta-2,4-dienoic acid ethyl ester
(26)
To a solution of 1,3-diene 23 (2.27 g, 5.80 mmol) and tert-butyl-
N-hydroxycarbamate20 (0.78 g, 5.80 mmol) in CH2Cl2 (15 mL) at
To a suspension of 3-ethoxycarbonylallylidenetriphenyl-arsonium
bromide23 (2.0 g, 4 mmol) in THF (10 mL) was added n-BuLi
(2.5 M in hexanes, 1.6 mL, 4 mmol) dropwise at 0 ◦C. The
red solution was stirred for 30 min at that temperature. 3-
Bromobenzaldehyde (0.23 mL, 2 mmol) was then added and the
reaction mixture was stirred for 1 h at 0 ◦C and 1 h at room
temperature before being quenched with a saturated aqueous
solution of NH4Cl. The aqueous phase was extracted with EtOAc
and the combined organic phases were dried over magnesium
sulfate, filtered and concentrated. The residue was purified by flash
chromatography on silica gel (cyclohexane–ethyl acetate = 90 : 10)
to give 339 mg (60%) of compound 26 as a slightly yellow oil.
1H NMR (300 MHz, CDCl3), d (ppm): 7.62 (1 H, t, J 1.7,
H Ar.); 7.47–7.37 (2 H, Ar.); 7.28–7.21 (2 H); 6.92–6.78 (2 H,
0
◦C was added Bu4NIO4 (2.51 g, 5.8 mmol) portionwise over
◦
30 min. After 1 h 30 min at 0 C, additional BocNHOH (0.2 g,
1.50 mmol) and Bu4NIO4 (0.4 g, 0.92 mmol) were added. The
reaction mixture was then hydrolyzed with water and the aqueous
phase was extracted with EtOAc. The combined organic phases
were washed with a 10% aqueous Na2S2O3 solution, dried over
magnesium sulfate, filtered and concentrated. The residue was
purified by flash chromatography on silica gel (cyclohexane–ethyl
acetate = 95 : 5 to 90 : 10) to give 2.15 g (71%) of compound 24
as a yellow oil that crystallized slowly to white crystals. 372 mg of
1,3-diene 23 (16%) were also recovered.
Mp: 97 ◦C. 1H NMR (300 MHz, CDCl3), d (ppm): 7.46–7.28 (10
H, 2 × Ph); 6.93 (1 H, s, Ar.); 6.87 (2 H, s, Ar.); 6.10 (1 H, ddd, J
=
=
=
Ar–CH CH–CH CH–CO); 6.04 (1 H, d, J 15.3, Ar–CH CH–
=
2.2, 4.3 and 10.3, OCH–CH CH–CHN); 5.99 (1 H, br. d., J 10.3,
=
CH CH–CO); 4.25 (2 H, q, J 7.2, OCH2CH3); 1.33 (3 H, t, J 6.9,
=
=
OCH–CH CH–CHN); 5.50 (1 H, br. s, OCH–CH CH–CHN
OCH2CH3). 13C NMR (75 MHz, CDCl3), d (ppm): 166.9 (CO),
143.8, 138.4, 138.1, 131.7, 130.3, 129.8, 127.6, 125.8, 122.4, 60.5
(OCH2CH3), 14.3 (OCH2CH3). LRMS (ES): m/z (%) = 598.0
(14), 473.0 (14), 438.2 (19), 416 (19), 237 (100).
=
or OCH–CH CH–CHN); 5.19 (2 H, s, CH2OCH2Ph); 4.76 (1 H,
=
=
br. s., OCH–CH CH–CHN or OCH–CH CH–CHN); 4.65 (1
H, d, J 12.0, ArOCH2Ph); 4.60 (1 H, d, J 12.0, ArOCH2Ph); 3.87 (3
H, s, OCH3); 3.84 (1 H, dd J 7.2 and 9.7, CH2OCH2Ph); 3.71 (1 H,
dd J 6.2 and 9.7, CH2OCH2Ph); 1.55 (9 H, s, OC(CH3)3). 13C NMR
(75 MHz, CDCl3), d (ppm): 154.4 (Ar. Quat.), 149.5 (Ar. Quat.),
148.5 (Ar. Quat.), 138.0 (Ar. Quat.), 136.8 (Ar. Quat.), 129.9, 128.8,
128.4, 128.2, 127.7, 127.4, 127.0, 124.7, 120.8 (Ar.), 113.5 (Ar.),
111.8 (Ar.), 81.5 (OCMe3), 78.3 (OCHPh), 73.1 (OCH2Ph), 70.8
(OCH2Ph), 70.5 (CH2OCH2Ph), 55.8 (CH3O), 53.7 (br, CHN),
1-((1E,3E)-5-Benzyloxy-penta-1,3-dienyl)-3-bromo-benzene (27)
To a solution of ester 26 (0.275 g, 0.98 mmol) in CH2Cl2 (4.9 mL) at
0 ◦C was added DIBAL (1.5 M in toluene, 1.57 mL, 2.35 mmol).
The solution was slowly warmed to room temperature over 1 h
and transferred carefully to a saturated aqueous solution of
This journal is
The Royal Society of Chemistry 2008
Org. Biomol. Chem., 2008, 6, 1063–1070 | 1067
©